Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
DSP Group to Participate in the 36th Annual Canaccord Genuity Growth Conference
-
Ducommun Announces Upcoming Investor Events
-
ContraVir Pharmaceuticals to Present at the 2016 Canaccord Genuity Growth Conference
-
Tactile Systems Announces Pricing of Initial Public Offering
-
After-Hours Stock Movers 07/27: (PCMI) (GRPN) (CRUS) (FB) Higher; (INFN) (ARGS) (RCII) Lower (more...)
-
Exact Sciences (EXAS) Falls 4% on Plans to Sell 7M Common Shares
-
GenMark Diagnostics to Present at the 36th Annual Canaccord Genuity Growth Conference
-
Senseonics Holdings, Inc. to present at Canaccord Genuity’s Growth Conference
-
MiX Telematics to Present at Upcoming Investor Conferences
-
The Chefs’ Warehouse, Inc. to Present at the 36th Annual Canaccord Genuity Growth Conference
-
Rightside® to Present at the Canaccord Genuity Growth Conference on August 10, 2016
-
Vascular Solutions to Present at the Canaccord Genuity Growth Conference
-
AppliedMicro to Present at Upcoming Investor Conferences
-
Entellus Medical to Present at the Canaccord Genuity Growth Conference
-
Exact Sciences Announces Agreement to Sell 7,000,000 Common Shares
-
Ameresco to Present at Upcoming Investor Conferences
-
UPDATE: Canaccord Genuity Downgrades Globus Medical (GMED) to Hold
-
UPDATE: Canaccord Genuity Downgrades Twitter, Inc. (TWTR) to Hold
-
Edwards Lifesciences (EW) PT Raised to $140 at Canaccord Genuity
-
As iPhone sales stagnate, services promise growth for Apple
-
Asure Software to Present at Canaccord Genuity’s 36th Annual Growth Conference on August 10, 2016
-
Twitter's video push seen taking time to fast-forward growth
-
Histogenics Corporation to Present at the Canaccord Genuity Growth Conference
-
Boeing posts lower-than-expected second-quarter loss, stock gains
-
Carbonite to Present at Upcoming Financial Conferences
-
Impinj, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
InvenSense Inc. Announces Financial Conference Participation For The Fiscal Second Quarter 2017
-
Cardiome Pharma (CRME) Prices 10M Stock Offering at $3/Share
-
Cardiome Announces Pricing of Public Offering of 10,000,000 Common Shares
-
Clearfield to Present at Canaccord Genuity’s 36th Annual Growth Conference on August 11, 2016
-
American Hotel Income Properties REIT LP Announces Completion of CDN$103.5 Million Bought Deal
-
Canaccord Genuity Downgrades Rockwell Collins (COL) to Hold
-
Axis Auto Finance Inc. (Formerly Verdant Financial Partners I Inc.) Announces Closing of Its Qualifying Transaction, Share Consolidation, and Name Change
-
Ultratech to Present at Canaccord Genuity Growth Conference on August 11
-
Kornit Digital to Present at the 2016 Canaccord Genuity Growth Conference
-
EnerNOC to Present at Upcoming Investor Events
-
Atalaya Mining PLC Announces Second Quarter 2016 Operational Update
-
AtriCure to Present at the Canaccord Genuity Growth Conference
-
TPI Composites (TPIC) IPO Opens Modestly Higher
-
Canaccord Genuity Upgrades Celestica (CLS) to Buy
-
TPI Composites Prices Initial Public Offering
-
Mattersight to Present at the Canaccord Genuity 36th Annual Growth Conference
-
AltaGas Ltd. Reports Strong Second Quarter Results and Increases Dividend 6.1 Percent
-
Impinj, Inc. Announces Pricing of Initial Public Offering
-
Nobilis Moves Forward with New President and New Canaccord Coverage
-
Datawatch (DWCH) Misses Q3 EPS by 15c; Will Review Strategic Alternatives
-
Datawatch Announces Third Quarter Fiscal 2016 Financial Results
-
Datawatch Announces Third Quarter Fiscal 2016 Financial Results
-
Veresen Announces Common Share Dividend for July 2016
-
IDEXX Laboratories (IDXX) PT Raised to $98 at Canaccord Genuity Following Vet Survey

